Japan System Techniques Co.,Ltd. Q4 FY2025 earnings call

• Company Overview & Core Competitiveness

  • Japan System Technique is an independent system development company focused on industry-specific products for the education, finance, and healthcare sectors, built on a foundation of corporate system integration services.
  • Key product adoption track records: GAKUEN has been implemented at 477 universities, BankNeo has been adopted by 64 financial institutions cumulatively, and the medical big data business has served more than 10 million patients.
  • Core competitive advantages: The company has decades of experience supporting mission-critical operations in education, finance and healthcare, and integrates regulatory compliance with end-to-end operational support. Core systems are difficult to replace, and continuous functional updates aligned with regulatory changes create recurring renewal demand, building high barriers to entry for new competitors.

• Growth Tailwinds from National Policy

  • Medical sector: Medical insurer DX and data health initiatives are supported by Japanese national policy. Starting in fiscal 2024, the Japanese Ministry of Health, Labour and Welfare launched the 3rd Phase Data Health Plan for the Late-Stage Elderly Medical Care Regional Unions, which has standardized planning formats and set evaluation indicators, laying the foundation for data-driven policy implementation. Additionally, the national Medical DX initiative proposes a national medical information platform that allows medical institutions, patients, and insurers to access health check-up information, expanding demand beyond receipt inspection to include data analysis and policy operation support. The company's full-suite medical big data business, covering receipt inspection, analysis, and operational support, has high alignment with these new regulatory initiatives, creating strong growth tailwinds.
  • Education sector: The Japanese Ministry of Education, Culture, Sports, Science and Technology's Education DX Roadmap promotes nationwide standardized digitalization of higher education processes, including university entrance examinations and academic history certificates. This is expected to increase demand from universities for integrated system upgrades that cover core administrative operations plus peripheral services such as digital certificate management and identity verification. As GAKUEN is already the core of university academic affairs operations, it is well-positioned to capture new demand for regulatory compliance updates and peripheral functional additions, leading to sustained recurring renewal demand.

For the fiscal year ending March 2025, the segment performance is as follows: 1. DX & SI: 17.54 billion yen in revenue, accounting for 59.8% of total revenue. This segment covers cloud infrastructure construction and operation, data utilization and other services. 2. Package Products: 5.88 billion yen in revenue, accounting for 20.0% of total revenue. This segment includes the university business package GAKUEN and the finance-focused package BankNeo. 3. Medical Big Data: 3.15 billion yen in revenue, accounting for 10.7% of total revenue. This segment includes automatic receipt inspection JMICS and data health support services. 4. Global: 2.75 billion yen in revenue, accounting for 9.4% of total revenue. This segment covers SAP implementation support and other related services.

• Long-term growth: The company's long-term vision JAST VISION 2035 sets a target of 100 billion yen in consolidated group revenue by 2035, which requires average annual revenue growth of just over 10% to achieve. Growth will be driven by deepening penetration of medical big data among existing insurer clients and expanding peripheral services around the GAKUEN platform in the education ICT sector.
• Dividend policy: The company targets a dividend payout ratio of 30% or a dividend on equity (DOE) of 4% as its shareholder return guideline. For the fiscal year ending March 2026, the company plans to pay an annual dividend of 35 yen per share.

No explicit discussion of risks or operational failures is included in the provided transcript.

No question and answer section is included in the provided transcript.